Member Info for mazik

150 k at 1.95...topped up a good bargain

In that case I will keep an eye to top up, I feel it could multibag as few shares and cash equivalent to market cap so minimum 8p...is for certain :-)

At this price got a few 105k, thanks double your investment in 6 months..imo

A great share to be holding...another multiples ahead of us :-)

Hah! Hah! Pettycash... I take your point my crystal ball has been been given to Oxfam charity shop as it has been useless...predicting..lol !

well its a good friday closing should move to 4p next week...imo

The exclusive development of NXP001 in China with applications in oncology supportive care. with Newsummit who have agreed to pay aggregate fee of �2,500,000 in addition to double-digit royalty on all Newsummit revenues derived from NXP001. Newsummit has over the past 10 years a good reputation in the pharmaceutical and biotech industry and constantly growing its market influence, well i am confident NFX have access to the biggest market to exploit NXP001, Feel we are in the verge f being rerated once the market recognises the potential..imo

alogrithmic trading will take this over multiple of todays price when the news takes over and attracts buyers..way oversold..imo

low volume and mm's are accumalating fom the impatient 9% down on 86k shares, what a joke :-)

Hah! Hah! yes joker :-)

dajj nothing happening at the moment as I have said and investors realise its fully funded . Nuformix is targeting high-value unmet needs with its lead programmes in oncology supportive care: NXP001 and fibrosis: NXP002.Significant early revenue and a potential mid-term royalty stream, partnership with Newsummit, who have developed a proven working relationship in the transfer of our technology to China. NXP001 represents a unique opportunity to deliver an affordable innovative healthcare product we are already derisked our future whilst we are looking to expand in US and Europe. WE should be rerated accordingly and expected news sp will be revived accordingly, I dont need to say much as confident as I am I have over a million shares and I expect it market cap to be around �50 miilion this year IMO . Uk is busy promoting their bio technology to China , Japan and USA...we are No 1 in this field..so lets wait for licencing deals...then you will not expect us to be silent :-)

This will move over 4p now when investors realise we are fully funded and over sold imo

get ready for a lift off :-)

Agree with u Aim....I have topped my holding over a mill ...well getting a stock 30 % cheaper than flotatiion price its too tempting :-) and seeing it double in Value in April will be a delight :-)

Its a main listed stock "Nuformix was established in Cambridge in 2008 and has invested into pharmaceutical cocrystal R&D, establishing world-class capability and know-how in cocrystal discovery and development, yielding multiple product opportunities and revenues from products under development. Nuformix plc shares are traded on the London Stock Exchange's Official List under the ticker: NFX.L. Great its not a Aim stock it will trigger a wider audience instituitions and fund managers...GLA

l might not be heavily invested i have around 800k shares for the long run .......GLA

Thanks Aim4U i am here for the long journey and expect a good run with NFX

keeping the sp price down,its the mm's agenda, i believe there is big buyer at the background

well done who bought in on weaknes of mm's rinse and repeat...

well fully topped up i agree....its the best to follow for 2018